Medtronic’s fiscal years wrap up at the end of April.
Speaking on the company’s second-quarter earnings call, Chair & CEO Geoff Martha said Medtronic expects its MiniMed 780G insulin pump system with the Guardian 4 sensor for continuous glucose monitoring (CGM) to drive growth once approved, with the company currently in talks with the FDA.
Get the full story at our sister site, Drug Delivery Business News.